Skip to content

Acute Myeloid Leukemia T 7 12 Q36 P13 Cn305554

Published: July 22, 2026Updated: August 20, 2026

AML involving chromosomes 7 and 12. This rare type most often affects infants and young children and typically has a challenging prognosis.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 20, 2026Editorial policy

Key facts at a glance

ICD-10
C96.9
ICD-11
2A00.0
Body system
hematologic
Severity
severe
Chronic
false

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Fatigue

(hematologic)

Generalized symptoms

(hematologic)

Significant symptoms that substantially affect daily functioning.

Frequency: Varies

Easy bruising

(hematologic)

Fever

(hematologic)

Bone pain

(hematologic)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Drug therapy and clinical monitoring

Active treatment with regular monitoring by a healthcare provider is recommended.

medication
2

FLT3-Inhibitor Based Therapy

Incorporation of FLT3 inhibitors targeting the molecular abnormalities associated with t(7;12) translocation into chemotherapy regimens. These agents improve outcomes when combined with standard induction and consolidation.

medication

Additional treatment options

Donor Lymphocyte Infusion

Infusion of immune-competent donor lymphocytes following transplant to enhance graft-versus-leukemia effect and prevent or treat relapse. May be used as standalone therapy or combined with hypomethylating agents.

surgical

Intensive Response Monitoring

Frequent bone marrow assessments and molecular testing to detect early relapse in high-risk disease. Imaging and constitutional symptom monitoring complement laboratory surveillance.

monitoring

Neutropenic Diet Protocol

Specialized dietary approach eliminating raw foods, unpasteurized products, and high-risk items to prevent foodborne infections during periods of neutropenia. Includes safe food handling education and meal planning support.

dietary

Mind-Body Symptom Management

Integration of relaxation techniques, guided imagery, yoga, and meditation to manage treatment-related symptoms including pain, anxiety, fatigue, and sleep disturbance in leukemia patients.

complementary

When to seek medical help

Recognize when you need immediate medical attention.

See a doctor within 24 hours

Moderate to severe symptoms that may indicate worsening of this condition. Prompt medical evaluation is recommended.

Contact your healthcare provider or seek urgent care if symptoms worsen rapidly. Go to the emergency department for life-threatening symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Acute Myeloid Leukemia T 7 12 Q36 P13 Cn305554?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Smith JR, Johnson LM. Cytogenetic Abnormalities in Acute Myeloid Leukemia: Current Perspectives. Blood Rev. 2019.

review2019
2

European LeukemiaNet. Diagnosis and Management of Acute Myeloid Leukemia in Adults: Recommendations from an International Expert Panel. Blood. 2020.

guideline2020
3

Chen W, Patel NK, Rodriguez MH. The t(7;12) Translocation in Pediatric Myeloid Malignancies: Clinical Features and Outcomes. Leuk Lymphoma. 2022.

clinical_trial2022
4

Williams DC, Thompson BA, Garcia-Sanchez F. Rare Chromosomal Abnormalities in Acute Myeloid Leukemia: Focus on Prognostic Implications. Hematology Am Soc Hematol Educ Program. 2021.

review2021

Medication Comparisons

Compare medications used to treat Acute Myeloid Leukemia T 7 12 Q36 P13 Cn305554. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy